Literature DB >> 375939

Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus.

H A Wilson, J B Winfield, R G Lahita, D Koffler.   

Abstract

Sera from 20 patients with systemic lupus erythematosus (SLE) and active central nervous system (CNS) dysfunction were examined by indirect immunofluorescence for antibodies to neuronal membrane determinants. Warm-reactive IgG antibodies were demonstrable in 82% (9/11) of patients with clinical evidence for seizures or diffuse CNS disease, but these antibodies generally were absent in non-CNS SLE sera or when focal neurologic deficit or psychosis was the primary CNS manifestation. Cold-reactive antibodies of the IgM class were equally prevalent in patients with or without CNS disease and appeared to be more directly correlated with extra-CNS systemic illness. Absorption experiments with lymphocytes, brain homogenate, and various other tissues suggested a predominant brain-specificity for IgG antibodies and partial lymphocyte cross-reactivity for IgM antibodies. Interpretations of this special association between IgG anti-brain antibodies and diffuse CNS dysfunction in SLE are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 375939     DOI: 10.1002/art.1780220504

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  28 in total

Review 1.  Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology.

Authors:  J B Harley; R H Scofield
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

Review 2.  Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.

Authors:  D P Ankeny; P G Popovich
Journal:  Neuroscience       Date:  2008-07-04       Impact factor: 3.590

3.  Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies.

Authors:  L T Costallat; R M de Oliveira; M B Santiago; W Cossermelli; A M Samara
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

Review 4.  Immunopathogenesis of the neuropsychiatric manifestations of systemic lupus erythematosus.

Authors:  H G Bluestein; K D Pischel; V L Woods
Journal:  Springer Semin Immunopathol       Date:  1986

5.  Is immunogenetic susceptibility to neuropsychiatric systemic lupus erythematosus (SLE) different from non-neuropsychiatric SLE?

Authors:  L M Silva; E A Donadi
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

6.  Clinical neurophysiology in the assessment of neurological symptoms in systemic lupus erythematosus.

Authors:  A B Mongey; D Glynn; M Hutchinson; B Bresnihan
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

7.  The pathogenesis of neuropsychiatric lupus.

Authors:  J A Denburg; P Temesvari
Journal:  Can Med Assoc J       Date:  1983-02-01       Impact factor: 8.262

8.  In vivo two-photon microscopy reveals immediate microglial reaction to implantation of microelectrode through extension of processes.

Authors:  Takashi D Yoshida Kozai; Alberto L Vazquez; Cassandra L Weaver; Seong-Gi Kim; X Tracy Cui
Journal:  J Neural Eng       Date:  2012-10-17       Impact factor: 5.379

9.  Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients.

Authors:  T Hirano; H Hashimoto; Y Shiokawa; M Iwamori; Y Nagai; M Kasai; Y Ochiai; K Okumura
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

10.  Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations.

Authors:  P Colamussi; M Giganti; C Cittanti; L Dovigo; F Trotta; M R Tola; R Tamarozzi; G Lucignani; A Piffanelli
Journal:  Eur J Nucl Med       Date:  1995-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.